Cyrusone (CONE) Misses Q2 EPS by 10c

Cyrusone (NASDAQ: CONE) reported Q2 EPS of ($0.06), $0.10 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $81.7 million versus the consensus estimate of $79.42 million.

Normalized Funds From Operations (Normalized FFO)3 was $25.6 million for the second quarter, compared to $16.0 million in the same period in 2013, an increase of 60%. The increase in Normalized FFO was primarily due to growth in Adjusted EBITDA. Normalized FFO per diluted common share or common share equivalent4 was $0.39 in the second quarter of 2014. Adjusted Funds From Operations (AFFO)5 was $25.3 million for the second quarter, compared to $14.8 million in the same period in 2013, an increase of 71%.

For earnings history and earnings-related data on Cyrusone (CONE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Cisco rating cut at HSBC as analyst sees a lack of catalysts